Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Madeleine Besnard"'
Autor:
Yves Cohen, Madeleine Besnard
Publikováno v:
Principles of Radiopharmacology ISBN: 9780429288760
Principles of Radiopharmacology
Principles of Radiopharmacology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b6c4ade5b46338abf3153c663925b5e
https://doi.org/10.1201/9780429288760-9
https://doi.org/10.1201/9780429288760-9
Autor:
Carolina Gómez-Gaete, Amélie Bochot, Nicolas Tsapis, Madeleine Besnard, Elias Fattal, Claudie Bourgaux, Lídia Silva
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 70:116-126
We describe the supramolecular organization of hybrid microparticles encapsulating dexamethasone (DXM) prepared by spray drying 1,2-Dipalmitoyl-sn-Glycero-3-Phosphocholine (DPPC) and hyaluronic acid (HA). The effect of DXM concentration on size distr
Autor:
Gilles Ponchel, J. Kablan Brou, Armand Koffi, Florence Agnely, Madeleine Besnard, Jean-Louis Grossiord
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 69:167-175
The aim of this work was to improve the rectal bioavailability of quinine hydrochloride by designing thermosensitive and mucoadhesive gels intended for rectal delivery. The rheological and mucoadhesive properties of poloxamer 407 solutions have been
Publikováno v:
Journal of Controlled Release. 128:41-49
We have combined the therapeutic potential of nanoparticles systems with the ease of manipulation of microparticles by developing a hybrid vector named Trojan particles. We aim to use this new delivery vehicle for intravitreal administration of dexam
Autor:
Claudie Bourgaux, Muriel Lalanne, Michel Ollivon, Didier Desmaële, M. Ré, Madeleine Besnard, Angelo Paci, Karine Andrieux, Patrick Couvreur
Publikováno v:
International Journal of Pharmaceutics. 344:62-70
Didanosine is a polar drug with poor membrane absorption and high hepatic first pass metabolism. This study aimed at developing a lipidic formulation of a glycerolipidic prodrug of didanosine in order to improve its bioavailability. In the course of
Publikováno v:
International Journal of Pharmaceutics. 331:153-159
The present paper concerns both the optimization of dexamethasone (DXM) entrapment and its release from biodegradable poly( d , l -lactide- co -glycolide) (PLGA) nanoparticles prepared by the solvent evaporation process. Since the addition of DXM ind
Autor:
Madeleine Besnard, E. Checroun, Pierre Tchoreloff, Paul Dumas, Ph. Walter, Jean Susini, Marine Cotte
Publikováno v:
Talanta. 70:1136-1142
Lead soaps can be found in archaeological cosmetics as well as in oil paintings, as product of interactions of lead salts with oil. In this context, a better understanding of the formation of lead soaps allows a follow-up of the historical evolution
Autor:
Philippe M. Loiseau, Madeleine Besnard, Cécile Menez, Robert Farinotti, Gillian Barratt, Marion Buyse
Publikováno v:
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2006, 50, pp.3793-3800. ⟨10.1128/AAC.00837-06⟩
Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2006, 50, pp.3793-3800. ⟨10.1128/AAC.00837-06⟩
The aim of this study was to evaluate the potential of a combination of two antileishmanial drugs, miltefosine (HePC) and amphotericin B (AMB), when administered by the oral route. Caco-2 cell monolayers were used as a validated in vitro model of the
Publikováno v:
International Journal of Pharmaceutics. 324:37-42
Nucleoside analogues are widely used in the treatment of various viral infections. However, the poor in vivo conversion of the nucleoside analogues like azidothymidine (AZT) into their active triphosphate nucleotide counterpart limits their pharmacol
Autor:
Amélie Bochot, Madeleine Besnard, Francine Behar-Cohen, Elias Fattal, Florence Siepmann, Aoife Doyle, Juergen Siepmann, Jeannette Schmaler, Ana L. Gomes dos Santos, Nicolas Tsapis
Publikováno v:
Journal of Controlled Release. 112:369-381
The purpose of this study was to design microspheres combining sustained delivery and enhanced intracellular penetration for ocular administration of antisense oligonucleotides. Nanosized complexes of antisense TGF-beta2 phosphorothioate oligonucleot